A Study Evaluating Chemotherapy With Fractionated Cisplatin/Gemcitabine Versus Carboplatin/Gemcitabine in the Treatment of Advanced or Metastatic Urothelial Cancer With Impaired Renal Function.
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Brentuximab Vedotin, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Pembrolizumab (MK-3475) Versus Platinum-Based Chemotherapy for Participants With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (MK-3475-042/KEYNOTE-042)
- Status
- COMPLETED
- Phase
- PHASE3
Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas
- Status
- UNKNOWN
- Phase
- PHASE2
Dose Escalation of Neoadjuvant Proton Beam Radiotherapy With Concurrent Chemotherapy in Locally Advanced Esophageal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Leukemia SPORE Phase II DAC Study for R/R and Elderly Acute AML and MDS
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Carboplatin Plus Gemcitabine for Elderly Patients With Stage IV NSCLC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors
- Status
- COMPLETED
- Phase
- PHASE2